These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2876441)

  • 41. Presynaptic autoinhibition of the electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry.
    Suaud-Chagny MF; Ponec J; Gonon F
    Neuroscience; 1991; 45(3):641-52. PubMed ID: 1775239
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations in peripheral and central dopamine receptor sensitivity after subchronic treatment with fluphenazine and sulpiride.
    Hietala J; MacDonald E; Syvälahti E; Scheinin M
    Pharmacol Toxicol; 1987 Jul; 61(1):48-52. PubMed ID: 3628181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Behavioral deficits induced by low doses of apomorphine in rats: evidence for a motivational and cognitive dysfunction which discriminates among neuroleptic drugs.
    Carnoy P; Ravard S; Wemerman B; Soubrie P; Simon P
    Pharmacol Biochem Behav; 1986 Sep; 25(3):503-9. PubMed ID: 2877466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats.
    Parry TJ; Eberle-Wang K; Lucki I; Chesselet MF
    Exp Neurol; 1994 Aug; 128(2):181-90. PubMed ID: 7915675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of Parkinsonism: role of priming.
    Morelli M; Fenu S; Cozzolino A; Di Chiara G
    Neuroscience; 1991; 42(1):41-8. PubMed ID: 1830642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine.
    Mereu G; Collu M; Ongini E; Biggio G; Gessa GL
    Eur J Pharmacol; 1985 May; 111(3):393-6. PubMed ID: 3894035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Do neuroleptics prevent the penetration of dopamine agonists into the brain?
    Westerink BH; Horn AS
    Eur J Pharmacol; 1979 Sep; 58(1):39-48. PubMed ID: 40803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of dopamine and its agonists and antagonists on the receptive field properties of ganglion cells in the rabbit retina.
    Jensen RJ; Daw NW
    Neuroscience; 1986 Mar; 17(3):837-55. PubMed ID: 3703255
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist.
    Dias FR; de Matos LW; Sampaio Mde F; Carey RJ; Carrera MP
    Behav Brain Res; 2012 Apr; 229(1):153-9. PubMed ID: 22244923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N; Saito K; Hirata A; Iwatsubo K; Noguchi Y; Yoshida H
    Brain Res; 1980 Oct; 199(2):335-42. PubMed ID: 7417787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats.
    Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1985; 86(1-2):228-32. PubMed ID: 3927361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.
    Costall B; Naylor RJ; Nohria V
    Eur J Pharmacol; 1978 Jul; 50(1):39-50. PubMed ID: 28233
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide.
    Molloy AG; Waddington JL
    Eur J Pharmacol; 1985 Feb; 108(3):305-8. PubMed ID: 3886407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs.
    Nielsen EB; Jepsen SA
    Eur J Pharmacol; 1985 May; 111(2):167-76. PubMed ID: 2862045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Neuroleptic properties of Y-516, a new iminodibenzyl derivative].
    Fukuda T; Setoguchi M; Morimoto Y; Shoji H; Tsumagari T; Maruyama Y
    Nihon Yakurigaku Zasshi; 1985 Sep; 86(3):197-208. PubMed ID: 2867957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of drinking by naltrexone in the rat: interaction with the dopamine D-1 antagonist SCH 23390 and the D-2 antagonist sulpiride.
    Ukai M; Nakayama S; Kameyama T
    Pharmacol Biochem Behav; 1989 Mar; 32(3):651-5. PubMed ID: 2662222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metoclopramide and sulpiride as selective blocking agents of pre- and postsynaptic dopamine receptors.
    Alander T; Andén NE; Grabowska-Andén M
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):145-50. PubMed ID: 7402361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The amphetamine conditioned place preference: differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas.
    Hiroi N; White NM
    Brain Res; 1991 Jun; 552(1):141-52. PubMed ID: 1833032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats.
    Chipkin RE
    Pharmacol Biochem Behav; 1988 Jul; 30(3):683-6. PubMed ID: 2974995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.